OrthoTrophix
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
303 Hegenberger Rd Ste 312, Oakland, Cal...Phone Number
(510) 488-3832Website
www.orthotrophix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About OrthoTrophix
OrthoTrophix is a biopharmaceutical company dedicated to developing and commercializing innovative therapies for diseases affecting hard tissues like bone and cartilage. The company is primarily focused on creating a first-in-class disease modifying osteoarthritis drug (DMOAD), with its leading compound, TPX-100, showing promising safety and efficacy in improving knee osteoarthritis symptoms. OrthoTrophix aims to provide significant clinical benefits by addressing the underlying pathological changes in bone and cartilage structures associated with osteoarthritis. Their target clients include patients suffering from knee osteoarthritis, as well as healthcare providers involved in their treatment.Explore more
OrthoTrophix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OrthoTrophix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
OrthoTrophix, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on OrthoTrophix recently announced quarterly report
Click to see if OrthoTrophix had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if OrthoTrophix is spiking on competitors!
Check if OrthoTrophix has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at OrthoTrophix
Funding: Get notified immidiatlly once OrthoTrophix has new funding data
Product Launch: Get notified when OrthoTrophix launches new products
Recommended Actions
Find VP level buyers at OrthoTrophix
Find more new buyers
Compare Similar Companies to OrthoTrophix
Compare insights from companies similar to OrthoTrophix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
OrthoTrophix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
OrthoTrophix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about OrthoTrophix.
OrthoTrophix Tech Stack
A closer look at the technologies used by OrthoTrophix
OrthoTrophix News & Media
OrthoTrophix Announces Early Completion of Enrollment in Phase 2b Trial of TPX-100 in Knee Osteoarthritis
FOSTER CITY, Calif., Feb. 24, 2026 /PRNewswire/ -- OrthoTrophix, Inc., a privately held biopharmaceutical company developing novel investigational therapies for osteoarthritis, today announced the early completion of the planned patient enrollment in its Phase 2b clinical trial evaluating...TPX-100: OrthoTrophix Presents the Latest Clinical Data at BIO 2022
FOSTER CITY, Calif., June 1, 2022 /PRNewswire/ -- OrthoTrophix, Inc., a privately held biopharmaceutical company, announced today that the Company will present the latest clinical data and registration plan of TPX-100 in knee osteoarthritis (OA) patients at BIO 2022 (San Diego, CA for...TPX-100: OrthoTrophix Presents New Data Suggesting Joint Bone Shape as a Possible Surrogate Marker for Virtual Joint Replacement in Knee Osteoarthritis
FOSTER CITY, Calif., April 8, 2022 /PRNewswire/ -- OrthoTrophix, Inc., a privately held biopharmaceutical company, announced today that the Company and its collaborators present clinical data strongly supporting joint bone shape change as part of a surrogate marker predictive of joint...TPX-100: OrthoTrophix Published a New Research Article Demonstrating Disease Modification in Knee Osteoarthritis
FOSTER CITY, Calif., Sept. 21, 2021 /PRNewswire/ -- OrthoTrophix, Inc., a privately held biopharmaceutical company, announced today that the Company and its collaborators have published a new research article presenting clinical data demonstrating disease modification in knee...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding OrthoTrophix
Sign Up For FreeTo access detailed company insights
OrthoTrophix is a biopharmaceutical company dedicated to developing and commercializing innovative therapies for diseases affecting hard tissues like bone and cartilage. The company is primarily focused on creating a first-in-class disease modifying osteoarthritis drug (DMOAD), with its leading compound, TPX-100, showing promising safety and effica... Read More
